Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Michael Lattanzi | Yesung Lee | Danny Simpson | Una Moran | Farbod Darvishian | Randie H Kim | Eva Hernando | David Polsky | Doug Hanniford | Richard Shapiro | Russell Berman | Anna C Pavlick | Melissa A Wilson | Tomas Kirchhoff | Jeffrey S Weber | Judy Zhong | Iman Osman
Journal of the National Cancer Institute | 2019

Two primary histologic subtypes, superficial spreading melanoma (SSM) and nodular melanoma (NM), comprise the majority of all cutaneous melanomas. NM is associated with worse outcomes, which have been attributed to increased thickness at presentation, and it is widely expected that NM and SSM would exhibit similar behavior once metastasized. Herein, we tested the hypothesis that primary histologic subtype is an independent predictor of survival and may impact response to treatment in the metastatic setting.

Pubmed ID: 29912415

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P30 CA016087
  • Agency: NCI NIH HHS, United States
    Id: P50 CA225450

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.